News

The patent number 8,114,874 was entitled, Substituted Acetylenic Imidazo[1,2-B] Pyridazine Compounds as Kinase Inhibitors. The new patent covers both the compound itself and its pharmaceutical compositions. Additional patent

Under the agreement, Health Management’s 66 hospitals in 15 states can upgrade to the latest version of McKesson’s AcuDose-Rx medication dispensing system to improve nursing workflow and optimize

Supera Farma is a Brazilian pharmaceutical company co-owned by Cristalia and Eurofarma. Merck will own 51% of the JV, managed by a joint board and leadership team, and

The European Commission approved tafamidis (the trade name in the European Union is VYNDAQEL) in November 2011, the company said. The FDA has granted the tafamidis NDA a

The LabNexus laboratory outreach solution is easy to navigate, secure, and accessible, enabling physicians to provide premium healthcare to their patients from anywhere they have an internet connection.

The comparative study will evaluate the potential increase in survival rates, thrombin levels and in vivo recovery of Factor VIIa-CTP. The study reported that Factor VIIa-CTP showed superior

The FDA request reflects a 17% increase over the FDA enacted budget for FY 2012. The FY 2013 request covers the period from 1 October 2012 through 30

The FBP vaccine comprises E39 peptide integrated with the immune adjuvant, granulocyte macrophage-colony stimulating factor (GM-CSF). The study will examine if the FBP vaccine is safe and effective

The results from the TBS-2 Phase II Vibrotactile Stimulation (VTS) study demonstrated that Tefina had met all study endpoints. The VTS study measured the occurrence of, time to